Results 21 to 30 of about 110,016 (261)
Objective: Population-wide mammographic screening programs aim to reduce breast cancer mortality. However, a broad view of the harms and benefits of these programs is necessary to favor informed decisions, especially in the earliest stages of the disease.
Julieta Politi +6 more
doaj +1 more source
Breast: Ductal carcinoma [PDF]
Classification Invasive ductal carcinoma is a heterogeneous group with many different subtypes, some of them extremely rare. Each of these variants is associated with another pathological presentation and with a different prognosis compared to invasive ductal carcinoma of no special type (NST).
Moelans, CB, van, Diest PJ
openaire +3 more sources
Down-regulation of C35 decreased the cell viability and migration of breast ductal carcinoma cells.
BackgroundResistance to human epidermal growth factor receptor-2 (HER2)-targeted therapies is common, and results in treatment failure and new tumor progression.
Wen Che, Yun Bao, Feng Tang
doaj +1 more source
Ductal carcinoma in situ of the male breast [PDF]
Ductal carcinoma in situ (DCIS) of the male breast is an uncommon disease, accounting for approximately 7% of all male breast carcinomas. Compared with invasive carcinomas of the breast, the prognosis associated with DCIS in men is excellent; however, clinical features, pathology, and treatment of this disease are not well defined in the literature ...
M G, Camus +9 more
openaire +2 more sources
Invasive Ductal Carcinoma of the Breast in a Transgender Man: A Case Report
There is limited literature about breast cancer in the transgender population. Very little is known about how gender-affirming hormone therapy affects their breast cancer risk.
Yujing J. Heng +6 more
doaj +1 more source
Isolated Uterine Metastasis of Invasive Ductal Carcinoma
Introduction. Most common metastasis sites of breast cancer are the lungs, bones, liver, and brain, whereas uterine involvement by metastatic breast disease is rare.
Deniz Arslan +5 more
doaj +1 more source
Invasive ductal carcinoma of breast with neuroendocrine differentiation: A case report
Primary invasive breast carcinoma with neuroendocrine differentiation is an uncommon presentation. We hereby report a case diagnosed as invasive ductal carcinoma with neuroendocrine differentiation in a 52‐year‐old female patient who presented with a ...
Vinayak Aryal +5 more
doaj +1 more source
Ductal carcinoma in situ of the breast
Ductal carcinoma in situ of the breast is a heterogeneous group of lesions with diverse malignant potential. It is the most rapidly growing subgroup in the breast cancer family; it is projected that more than 39,000 new cases will be diagnosed in the United States during 1999.
openaire +5 more sources
Steatotic HCC can be diagnosed by MRI and forms a pro‐tumor immune microenvironment with high expression of PD‐L1, M2 polarization of macrophages and activation of CAFs, which may be a good target for combined immunotherapy. Abstract Background and Aims Immunotherapy has become the standard‐of‐care treatment for hepatocellular carcinoma (HCC), but its ...
Hiroki Murai +29 more
wiley +1 more source
Ductal carcinoma in situ in men is incredibly rare and detection by conventional mammography and ultrasound is often challenging. We report an unusual case of a 50-year-old male, with no family history of breast cancer, who presented with an 8-year ...
Florian Reinhardt +5 more
doaj +1 more source

